drugset / Trial / NCT00499746

The Discriminative Effects of Tramadol in Humans

NCT00499746

Phase 1/2 Completed 20 enrolled National Institute on Drug Abuse (NIDA)
RandomizedCrossoverTriple-blindTreatment

Summary

This research is part of a set of studies whose purpose is to test whether tramadol can be used for the treatment of opioid addiction. Tramadol is already available in the United States as a pain medicine marketed as Ultram. It has effects similar to morphine, and it may also have effects similar to other drugs like stimulants. The doses of tramadol used in this study are higher than those generally used for the treatment of pain. To be in this study a participant must be a user of opioids (drugs like heroin) and stimulants (drugs like cocaine), but cannot be addicted to either. The person must be between 21-55 years old, and generally healthy. Up to 12 people will take part in this study.

Timeline

Start
2007-11
Primary completion
2010-04
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydromorphone Other / unclassified 4 mg Oral
Comparator Hydromorphone Other / unclassified 8 mg Oral
Comparator Methylphenidate Small molecule 30 mg Oral
Comparator Methylphenidate Small molecule 60 mg Oral
Comparator Tramadol Other / unclassified 50 mg Oral
Comparator Tramadol Other / unclassified 100 mg Oral
Comparator Tramadol Other / unclassified 200 mg Oral
Comparator Tramadol Other / unclassified 400 mg Oral